Roots Analysis has done a detailed study on Cell Therapy Media, Kits, Reagents and Surfaces Market, 2023-2035, covering key aspects of the industry’s evolution and identifying potential future growth opportunities.
Key Market Insights
Leveraging their expertise, over 450 types of kits, media, reagents and extracellular matrices have been manufactured by consumable providers for research and therapeutic purposes
The market features the presence of more than 80 firms across the globe; majority of these stakeholders are emerging players based in North America
A larger proportion of the kits available in the cell therapy domain comprise of different types of reagents; of these, 60% are intended for use with stem cell therapies and nearly 80% are stored in refrigerated conditions
Media developers are offering products for a broad range of cell therapies; nearly 90% of such players are providing media in the volume range of 100 to 500 ml
Predominantly, the cell therapy reagents are intended to be used at discovery scale of operation for a wide spectrum of functions, including cell expansion and proliferation
The market landscape of matrices, which typically have a shelf life of 1 to 1.5 years, is well distributed in terms of type of ECM coating and type of formulation
In pursuit of gaining a competitive edge, cell therapy consumable providers are upgrading their existing technologies and expanding their product portfolios
Many companies have undertaken strategic initiatives, including partnerships, acquisitions and expansions, to augment their existing capabilities
We expect industry stakeholders to continue to forge strategic alliances with niche / specialized players engaged in this domain to further augment their respective product offerings
Over the years, stakeholders within this industry have established strong brand positions by undertaking a range of initiatives to further advance the development of raw materials for cell therapies
Cost is a key determinant for the adoption of consumables in a cell therapy manufacturing process; the pricing strategy matrix is likely to assist players in evaluating the competitive market prices for their products
In 2035, the commercial scale of operation is likely to account for 75% of the total demand for cell therapy surface; this is attributed to the expected surge in the anticipated approvals of multiple cell therapies
A paradigm shift from animal-based to animal component free formulations, combined with stringent regulatory guidelines, is likely to drive the growth of the cell therapy media market at an annualized rate of 12%
The projected future opportunity for cell therapy consumable providers is expected to be well distributed across different types of end-users and key geographical regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Context and Background
3.2. Introduction to Cell Therapies
3.3. Comparison of Cell Therapies with Other Biopharmaceuticals
3.4. Classification of Cell Therapy Products
3.5. Overview of Cell Therapy Development and Manufacturing
3.6. Role of Raw Materials in Cell Therapy Development and Manufacturing
3.7. Types of Cell Therapy Consumables
3.8. Key Challenges Associated with Manufacturing of Cell Therapy Consumables
3.9. Future Perspectives
4. MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Cell Therapy Kit Providers
4.3. List of Cell Therapy Media Providers
4.4. List of Cell Therapy Reagent Providers
4.5. List of Cell Therapy Extracellular Matrix Providers
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Key Assumptions and Parameters
5.3. Methodology
5.4. Cell Therapy Consumables Providers: Company Competitiveness Analysis
5.5. Cell Therapy Kits Providers
5.6. Cell Therapy Media Providers
5.7. Cell Therapy Reagent Providers
5.8. Cell Therapy Extracellular Matrix Providers
6. BRAND POSITIONING OF KEY INDUSTRY PLAYERS
6.1. Chapter Overview
6.2. Scope and Methodology
6.3. Brand Positioning: STEMCELL Technologies
6.4. Brand Positioning: Miltenyi Biotec
6.5. Brand Positioning: Thermo Fisher Scientific
6.6. Brand Positioning: Takara Bio
6.7. Brand Positioning: GeminiBio
7. COMPANY PROFILES
7.1. Chapter Overview
7.2. STEMCELL Technologies
7.2.1. Company Overview
7.2.2. Product Portfolio
7.2.3. Recent Developments and Future Outlook
7.3. Miltenyi Biotec
7.4. Thermo Fisher Scientific
7.5. Bio-Techne
7.6. Irvine Scientific
7.7. Lonza
7.8. Sartorius
7.9. BD Biosciences
7.10. Corning
7.11. CellGenix
8. RECENT DEVELOPMENTS AND INITIATIVES
8.1. Chapter Overview
8.2. Partnership Models
8.3. Cell Therapy Consumables: Partnerships and Collaborations
8.4. Cell Therapy Consumables: Mergers and Acquisitions
8.5. Cell Therapy Consumables: Recent Expansions
9. LIKELY PARTNER ANALYSIS FOR CELL THERAPY CONSUMABLE PROVIDERS
9.1. Chapter Overview
9.2. Scoring Criteria and Key Assumptions
9.3. Scope and Methodology
9.4. Key Potential Strategic Partners for Cell Therapy Consumable Providers
10. ROOTS ANALYSIS PRICING STRATEGY
10.1. Chapter Overview
10.2. Roots Analysis Framework
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Scope and Methodology
11.3. Global Demand for Cell Therapy Consumables
11.4. Analysis by Scale of Operation
11.5. Analysis by Geography
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Methodology
12.3. Global Cell Therapy Consumables Market, 2023-2035
12.4. Cell Therapy Consumables Market: Analysis by Type of Product
12.5. Cell Therapy Consumables Market: Analysis by Type of Cell Therapy
12.6. Cell Therapy Consumables Market: Analysis by Scale of Operation
12.7. Cell Therapy Consumables Market: Analysis by Type of End-User
12.8. Cell Therapy Consumables Market: Analysis by Geography
13. UPCOMING TRENDS AND FUTURE GROWTH OPPORTUNITIES
13.1. Chapter Overview
13.2. Emerging Trends Related to Cell Culture Media
13.3. Automation of Cell Therapy Manufacturing Processes
13.4. Single Use Systems and Technologies in Cell Therapy Manufacturing
14. CONCLUDING REMARKS
15. INTERVIEW TRANSCRIPTS
16. APPENDIX I: TABULATED DATA
17. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/cell-therapy-consumables-market.html
Learn from experts: do you know about these emerging industry trends?
Unlocking the Potential of Digital Twins in Healthcare: Benefits, Challenges and Opportunities
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Posts
The rising demand for greater data reproducibility, accuracy and increased efficiency have prompted the healthcare laboratories to consider shifting from manually-handled processes to using lab automation systems.
Roots Analysis is pleased to announce the publication of its recent study, titled, “Lab Automation Market, 2023-2035”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these lab automation systems over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed assessment of the current market landscape of lab automation system manufacturers engaged in the manufacturing of various lab automation systems.
A detailed competitiveness analysis of lab automation system manufacturers based on several relevant parameters, such as company strength, product diversity and product strength.
Elaborate profiles of key players (shortlisted based on a proprietary criterion) engaged in the development of lab automation system across North America, Europe and Asia-Pacific and Rest of the World. Each profile features a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
A detailed analysis of partnerships inked between stakeholders engaged in this domain since 2018, based on several relevant parameters, such as year of partnership, type of partnership, type of partner, type of automation instrument(s), most active players (in terms of number of partnerships) and regional distribution of partnership activity in this domain.
An in-depth analysis of various patents that have been filed / granted related to lab automation since 2018, taking into consideration several relevant parameters, such as patent publication year, type of patent, patent jurisdiction, CPC symbols, type of applicant, emerging focus areas and leading players (in terms of number of patents filled / granted) and leading individual assignees. It also features a detailed patent benchmarking analysis and an insightful valuation analysis, highlighting the leading patents (in terms of number of citations).
A case study on the lab automation software providers, providing detailed analysis on various parameters such as year of establishment, company size (in terms of number of employees), location of headquarters, type of software, mode(s) of deployment, end-user(s).
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Stage of Automation
Pre-Analytical Stage
Analytical Stage
Post-Analytical Stage
Total Lab Automation
Type of Instrument
Automated Liquid Handling Systems
Automated Microplate Readers
Automated Sampling Systems
Analyzers
Automated Storage and Retrieval Systems (ASRS)
Other Instruments
End-User
Pharmaceutical and Biotechnology Companies
Research and Diagnostic Laboratories
Other End-Users
Key Geographical Region
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Key companies covered in the report
Abbott
Anton Paar
BD
Beckman Coulter
ERWEKA
Leuze
Ortho Clinical Diagnostics
Pall Corporation
PerkinElmer
Roche Diagnostics
Siemens Healthineers
SYSTAG
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html
News article
Digital Biomanufacturing Market
Learn from experts: do you know about these emerging industry trends?
SARM1: A Potential Therapeutic Target For Neurodegenerative Diseases
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
The “Conjugation and Labeling Services Market: Focus on Protein Labeling, Peptide Labeling, Small Molecule Conjugation and Antibody Conjugation, 2023-2035” report features an extensive study of the current market landscape, market size and the likely future potential of the conjugation and labeling services market, during the forecast period.
Key Inclusions
An executive summary of the insights captured during our research. It offers a high-level view on the current state of conjugation and labeling services market and its likely evolution in the mid-long term.
A general overview of conjugation and labeling of biomolecules, highlighting the various advantages of biomolecule conjugation and labeling. It also provides details on the different types of biomolecular conjugates and labels. Further, the chapter concludes with a discussion on various applications of the conjugated and labeled biomolecules in the biotechnology and pharmaceutical industry.
A detailed assessment of the overall market landscape of the companies offering conjugation and labeling services, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of molecule(s) supported (proteins, peptides, small molecules, antibodies and other molecules), type of molecular conjugate(s) / label(s) (polymers, haptens, enzymes, fluorescent tags, FRET pairs, quantum dots, carrier proteins, streptavidin, chelators, bead coupling / particle conjugates, isotopes, photoreactives and other molecular conjugates / labels) and conjugation service(s) offered.
A company competitiveness analysis of conjugation and labeling service providers based on company strength (in terms of years of experience and company size) and service strength (in terms of type of molecule(s) supported, type of molecular conjugate(s) / label(s) and conjugation service(s) offered).
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering conjugation and labeling services, located across North America, Europe and Asia-Pacific. Each profile features a brief overview of the company, recent developments and an informed future outlook.
A detailed analysis of the recent partnerships inked between stakeholders engaged in this domain, since 2018, covering acquisitions, service agreements, product development agreements, technology licensing agreements, and other relevant agreements.
An in-depth analysis of recent events (webinars / conferences / seminars / meetings / symposiums / summits) that were organized for stakeholders in the bioconjugation domain, based on several relevant parameters, such as year of event, event platform, type of event, geography, key focus areas, most active event organizers, active industry and non-industry players (in terms of number of speakers), seniority level of event speakers and geographical mapping of upcoming events.
A discussion on affiliated trends, key drivers and challenges, under a SWOT framework, featuring a Harvey ball analysis, highlighting the relative impact of each SWOT parameter on the overall conjugation and labeling services market.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Type of Molecule
Proteins
Peptides
Small Molecules
Antibodies
Other Molecules
Type of Molecular Conjugate / Label
Polymers
Haptens
Enzymes
Fluorescent Tags
Bead Coupling / Particle Conjugates
Quantum Dots
Isotopes
Other Molecular Conjugates / Labels
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
Frequently Asked Questions
What is the global market size of antibody conjugation services market?
Which are the leading companies in the antibody conjugation services market?
How many companies offer peptide conjugation services?
What percentage of service providers are engaged in offering conjugation and labeling services with both fluorescent tags and enzymes?
How many service providers offer services related to antibody-enzyme bioconjugation?
What are the major factors driving the conjugation and labeling services market?
What are the leading market segments in the conjugation and labeling services market?
Which region captures the highest share in the conjugation and labeling services market?
What is the likely growth rate (CAGR) for conjugation and labeling services market?
For additional details, please visit https://www.rootsanalysis.com/reports/conjugation-and-labeling-services-market.html
News article
Bioavailability Enhancement Services Market
Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Novel Cell Cytometers: Need of the Hour
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
Owing to the growing number of clinical trials and complexities associated with patient enrollment, drug developers are increasingly relying on patient recruitment service providers to expediate the drug development timelines
Roots Analysis is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Market (3rd Edition), 2022 – 2035.”
The report features an extensive study of companies engaged in offering patient recruitment services and patient retention services. The study features an in-depth analysis of the key drivers and trends related to this domain. Amongst other elements, the report includes:
A general overview of the clinical trials, patient recruitment process, patient recruitment associated services as well as the patient retention strategies employed to prevent drop-out of enrolled individuals from clinical trials.
A brief information on the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials.
A detailed assessment of the overall landscape of patient recruitment companies and patient retention companies offering these services.
A detailed competitiveness analysis of patient recruitment and retention service providers, segregated into three peer groups based on company size (small, mid-sized, and large and very large).
Elaborate profiles of prominent players offering patient recruitment and retention service, based in North America, Europe and Asia Pacific.
An analysis of the partnerships that have been inked by stakeholders engaged in this domain, from 2013-2022.
A review of the emerging trends in the patient recruitment industry, including the use of social media, mobile technologies, electronic health records (EHR), real-world evidence (RWE) and artificial intelligence.
A detailed discussion on the key growth opportunities in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.
A case study on regulatory landscape of patient recruitment, highlighting the regulatory process, guidelines and framework.
A brief overview of patient recruitment in clinical trials focused on personalized medicines and rare diseases.
A detailed analysis of the annual demand for study participants, taking into account the target patient population in ongoing and planned clinical trials, sponsored by both industry and non-industry players.
A detailed assessment on the impact of the COVID-19 pandemic on the patient recruitment and retention services market.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Patient Recruitment Step
Pre-screening
Screening
Trial Phase
Phase I
Phase II
Phase III
Phase IV
Therapeutic Area
Cardiovascular Disorders
Oncological Disorders
Infectious Diseases
CNS Disorders
Respiratory Disorders
Hematological Disorders
Dermatological Disorders
Ophthalmic Disorders
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Rest of the World
Transcripts of interviews held with the following senior level representatives of stakeholder companies:
Susan Fitzpatrick-Napier (Founder and Director, TrialWire)
Kate Shaw (Chief Executive Officer and Founder) and Marco Lassandro (Marketing and Communications Manager, Innovative Trials)
Simon Klaasen (Co-founder and Managing Director, Link2Trials)
Stefan Mayer-Eggersmann (Chief Commercial Officer, Clariness)
Ken Shore (Chief Commercial Officer, Continuum Clinical)
Hagit Nof (Chief Operation Officer and Business Development Officer, nRollmed)
Paul Ivsin (Ex-Managing Director, Seeker Health)
Kasturi Lakhe (Inside Sales Specialist, EVERSANA)
Key companies covered in the report
BBK Worldwide
Continuum Clinical
IQVIA
United BioSource (UBC)
WCG ThreeWire
Clariness
Fidelis Research
Ignite Data
Innovative Trials
Orphan Reach
3H Medi Solution
Buzzreach
Current Medical Information Center (CMIC)
nRollmed
Trialfacts
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/patient-recruitment-and-retention-services-market/245.html
News article
Global Cell Free Expression Market
Learn from experts: do you know about these emerging industry trends?
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
4D Bioprinting Market: Key Trends
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
Ben.johnson@rootsanalysis.com
Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain
The USD 29.8 billion (by 2035) financial opportunity within digital twin market has been analyzed across the following segments:
Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
Orthopedic Disorders
Other Disorders
Type of Digital Twin
Process Twins
System Twins
Whole Body Twins
Body Part Twins
Area of Application
Asset / Process Management
Personalized Treatment
Surgical Planning
Diagnosis
Other Applications
End Users
Pharmaceutical Companies
Medical Device Manufacturers
Healthcare Providers
Patients
Other End Users
Key Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
Rest of the World
The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:
Babylon
ExactCure
ImmersiveTouch
Navv Systems
ThoughtWire
Unlearn.AI
The latest report also provides key insights for Digital Twin Technology and Digital Twins Providers
Table of Contents
Preface
Executive Summary
Introduction
Market Landscape
Key Insights
Company Competitiveness Analysis
Company Profiles
Partnerships and Collaborations
Funding and Investments Analysis
Berkus Start-up Valuation Analysis
Market Forecast
Conclusion
Executive insights
Appendix I: Tabulated data
Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-twins-market.html
You may also be interested in the following titles:
Buffer Preparation Market
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Quantum Computing in Drug Discovery Services Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com